This bill requires the Louisiana Department of Health to set minimum reimbursement rates for nonemergency medical transportation services used by Medicaid recipients. It establishes a minimum payment of $14.50 per trip plus $2.10 per mile for transportation providers. The Louisiana Department of Health must implement these changes by October 1, 2026, through a Medicaid state plan amendment. This policy change directly affects transportation providers serving Medicaid patients and the state's healthcare administration.
HB 1249 amends the rules governing school-based health centers to ensure their operations align with specific existing provisions within the same legislative section. This change directly affects the administration of health services provided to students by requiring consistency between different parts of the governing text. The bill does not introduce new services or funding but rather clarifies how current regulations should be interpreted and applied. By adding a reference clause, the legislation streamlines the legal framework for these health programs without altering their core functions.
This bill requires Louisiana Medicaid to cover FDA-approved weight loss medications for eligible adults over eighteen. To qualify, patients must have a BMI of 30 or higher with at least one related health condition like diabetes or hypertension, or a BMI of 35 or higher without additional conditions. Coverage will require prior authorization limited to verifying these eligibility criteria, with initial approval for six months and continued coverage depending on documented clinical improvement. The bill also prohibits step therapy requirements for these medications and mandates that the Department of Health implement the coverage while maintaining fiscal sustainability.
HB 775 modifies Louisiana law to expand when minors can consent to medical care without parental permission. It allows minors aged 13-17 to consent to treatment for pregnancy, sexually transmitted infections, substance misuse, and certain emergencies (like abuse or neglect), while requiring parental access to medical records. The bill also prohibits schools or facilities from providing preventive care to minors without parental consent and shields healthcare providers from liability for following these rules. It repeals prior provisions that permitted broader minor consent or school-based care without parental involvement. This directly affects minors, parents/guardians, healthcare providers, and schools in Louisiana.
HB 302 prohibits new permits for businesses to sell vapor products within 300 feet of school property lines. It directly affects businesses seeking to open or operate vapor product sales near schools, requiring them to be at least 300 feet away. The bill specifies measurement can be either by sidewalk path (in areas with sidewalks) or straight line, with the straight-line method applying only to new permits issued after its adoption. This policy change restricts where new vapor product businesses can operate near schools but does not affect existing businesses.
HCR 120 establishes the PACE Task Force to study GLP-1 medications, which are drugs used for diabetes and weight loss that have seen a massive increase in demand and cost in Louisiana. This concurrent resolution directs the task force to investigate how these drugs affect insurance premiums, accessibility for different income groups, and the long-term financial impact on both public and private insurers. The group will consist of representatives from state agencies, health plans, and medical providers, who will meet to analyze pricing differences between diabetes and weight loss uses before submitting their findings to the legislature by February 2027.
This resolution asks the Louisiana State University School of Health Sciences to study how environmental risks affect maternal health. The study must identify connections between chemical exposures and health issues like respiratory or reproductive problems and deliver a written report by July 1, 2027. Findings will be shared with state health committees and the legislative research library to help guide future public health policies. The measure does not create new laws or funding but serves as a formal request for research.
This bill requires Medicare Advantage plans to cover integrative care services, directly affecting millions of Americans enrolled in these private insurance options. The legislation mandates that these plans include coverage for such services starting on January 1, 2027, with a later date adjustment to January 1, 2028, as specified in the text amendments. By establishing this new coverage requirement, the bill aims to expand the range of treatments available to Medicare beneficiaries under their existing private plans.
HB 198 requires Louisiana's Medicaid program to reimburse ambulatory surgical centers at least 100% of the Medicare rate for gastroenterology procedures. This directly affects outpatient surgical centers providing these specific medical services and ensures they receive consistent, updated payments. The bill mandates annual reimbursement adjustments to match Medicare rate changes and requires the Louisiana Department of Health to implement these changes by October 1, 2026. It also authorizes the Department to create necessary rules under state administrative procedures. This policy change standardizes payments for a defined set of procedures, aiming to maintain provider access to Medicaid coverage.
SB 250 requires Louisiana's Office of Group Benefits to contract with healthcare providers to offer comprehensive weight management services to plan participants. These services include FDA-approved medications, medically appropriate compounded treatments, medical evaluations, prescribing oversight, and follow-up care. The bill directly affects individuals enrolled in group health benefit plans covered under Louisiana's state programs. It establishes a formal mechanism for the Office of Group Benefits to provide these specific health services through qualified external partners. The bill is currently under review by the Finance Committee after being prefilled on February 26, 2026.
